Compare Stocks: CVS vs. HCA

Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
CVSHCA
+69.65%+3.41%

Market Snapshot

Current market context for the selected companies.

Key Differences

A differences-first view of the selected companies using the same data shown in the comparison tables below.

6M Performance
CVS has the stronger six-month price performance (+23.4% vs -23.5% for HCA).
Revenue Growth
HCA currently shows the faster revenue growth rate (8.7% vs 7.1% for CVS).
Operating Margin
HCA currently shows the higher operating margin (15.2% vs 3.9% for CVS).
Forward P / E
CVS currently trades at the lower forward earnings multiple (11.4x vs 12.5x for HCA).

Performance

Absolute returns and relative performance versus SPY.

Metric CVSHCA
1 Month-2.0%-0.1%
1 Month vs SPY-2.4%-0.5%
3 Months+2.4%+13.1%
3 Months vs SPY+0.3%+11.0%
6 Months+23.4%-23.5%
6 Months vs SPY+10.0%-36.9%
1 Year+32.4%+0.4%
1 Year vs SPY+12.4%-19.7%
2 Years+70.5%+4.1%
2 Years vs SPY+32.1%-34.2%

Growth & Profitability

Operating growth, margins and capital efficiency.

Metric CVSHCA
Revenue Growth7.1%8.7%
Earnings Growth188.8%11.6%
Gross Margin13.6%42.6%
Operating Margin3.9%15.2%
Net Margin1.2%8.8%
Return on Equity6.2%
Return on Assets3.0%12.3%

Valuation

Common valuation multiples shown side by side.

Metric CVSHCA
P / E25.813.9
Forward P / E11.412.5
P / S0.31.1
P / B1.6-30.1
EV / Sales0.51.8
EV / EBIT11.812.1
P / FCF15.524.0
FCF Yield6.5%4.2%

Cash Flow & Balance Sheet

Cash generation and leverage context.

Metric CVSHCA
Free Cash Flow$8.08B$3.74B
Operating Cash Flow$14.78B$11.12B
Debt / Equity95.5%

Earnings Outlook

Upcoming earnings expectations when available.

Metric CVSHCA
Next Earnings2026-10-282026-10-23
EPS Estimate1.636.70
Revenue Estimate104.69B19.36B
EPS Growth+1.8%-3.8%
Revenue Growth+1.8%+1.1%
Analyst Coverage2219